CIK 0001937653
- Non-accelerated filer
- Smaller reporting company
Zymeworks Inc.
Sign in to watch- Ticker
- ZYME
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 883099146
- Phone
- +1 302-274-8744
- Business address
- 108 PATRIOT DRIVE, SUITE A, MIDDLETOWN, DE, 19709
- Former names
- Zymeworks Delaware Inc.
- 4 Open-market buy Director bought 97,349 shares at an average $12.61 ($1,227,309)
- 4 Open-market buy Director bought 127,198 shares at an average $12.92 ($1,643,248)
- 4 Open-market buy Director bought 228,463 shares at an average $12.55 ($2,866,553)
- 4 Open-market buy Director bought 1,081,980 shares at an average $12.13 ($13,120,914)
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 141,429 shares at an average $13.88 ($1,963,538)
- 4 Open-market buy Director bought 167,654 shares at an average $13.59 ($2,278,811)
- 4 Open-market buy Director bought 225,119 shares at an average $13.21 ($2,974,819)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Scientific Officer sold 21,200 shares at $14.92 ($316,391)
- 4 Open-market sale Chair & CEO sold 57,291 shares at $14.92 ($855,017)
- 4 Open-market sale EVP & Chief Medical Officer sold 11,110 shares at $14.92 ($165,807)
- 4 Open-market buy Director bought 363,369 shares at an average $14.64 ($5,321,176)
- 4 Open-market buy Director bought 130,309 shares at an average $14.44 ($1,882,115)
- 4/A Open-market buy Director bought 1,254,808 shares at an average $13.98 ($17,544,284)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 7 · 121 filings